Hindustan Bio Sciences (BOM:532041) Total Liabilities : ₹0.00 Mil (As of Dec. 2023)

View and export this data going back to 1996. Start your Free Trial

What is Hindustan Bio Sciences Total Liabilities?

Hindustan Bio Sciences's Total Liabilities for the quarter that ended in Dec. 2023 was ₹0.00 Mil.

Hindustan Bio Sciences's quarterly Total Liabilities increased from Mar. 2023 (₹25.40 Mil) to Sep. 2023 (₹26.11 Mil) but then declined from Sep. 2023 (₹26.11 Mil) to Dec. 2023 (₹0.00 Mil).

Hindustan Bio Sciences's annual Total Liabilities increased from Mar. 2021 (₹21.82 Mil) to Mar. 2022 (₹21.89 Mil) and increased from Mar. 2022 (₹21.89 Mil) to Mar. 2023 (₹25.40 Mil).

Hindustan Bio Sciences Total Liabilities Historical Data

The historical data trend for Hindustan Bio Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hindustan Bio Sciences Total Liabilities Chart

Hindustan Bio Sciences Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Liabilities

Get a 7-Day Free Trial

34.66

33.13

21.82

21.89

25.40

Hindustan Bio Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Total Liabilities	Get a 7-Day Free Trial															24.73	-	25.40	26.11	-

Hindustan Bio Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Hindustan Bio Sciences's Total Liabilities for the fiscal year that ended in Mar. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	14.181	+	(11.219	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	25.40

Total Liabilities	=	Total Assets (A: Mar. 2023 )	-	Total Equity (A: Mar. 2023 )
	=	32.866	-	7.466
	=	25.40

Hindustan Bio Sciences's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	0	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	N/A

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	N/A	-	N/A
	=	N/A

Hindustan Bio Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Hindustan Bio Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Hindustan Bio Sciences (BOM:532041) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hindustan Bio Sciences Ltd (BOM:532041) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

Road No. 2, Banjara Hills, H.No. 8-2-269/S, Plot No. 31, Sagar Co-Operative Housing Society, Hyderabad, TG, IND, 500034

Website

https://www.hindustanbiosciences.in

Hindustan Bio Sciences Ltd is an India-based company operating in the pharmaceutical and biotechnology sector. It is engaged in the trading of Drugs and Medicines. The company markets a nephrology product, Recombinant Human Erythropoietin, which is useful for the treatment of anemia associated with chronic renal failure. In addition, the firm also manufactures and markets pharmaceutical products in different forms such as tablets, capsules, drops, externals, and syrups. Its other formulations comprise Pantorest, Maxion, Edinil, Aromycin, Livohin and others. Geographically, the group sells its products within India and also exports it to other countries.

Hindustan Bio Sciences (BOM:532041) Headlines

No Headlines